Arslan, A. M. 2020. Clinical significance of c-MYC/EZH-2 expression and Merlin loss. 32nd EORTC-NCI-AACR symposium Molecular Targets and Cancer Therapeutics , (Brussels, Belgium), 42.

Arslan, A. M., (2020). Clinical significance of c-MYC/EZH-2 expression and Merlin loss . 32nd EORTC-NCI-AACR symposium Molecular Targets and Cancer Therapeutics (pp.42). Brussels, Belgium

Arslan, AHMET. "Clinical significance of c-MYC/EZH-2 expression and Merlin loss," 32nd EORTC-NCI-AACR symposium Molecular Targets and Cancer Therapeutics, Brussels, Belgium, 2020

Arslan, AHMET M. . "Clinical significance of c-MYC/EZH-2 expression and Merlin loss." 32nd EORTC-NCI-AACR symposium Molecular Targets and Cancer Therapeutics , Brussels, Belgium, pp.42, 2020

Arslan, A. M. (2020) . "Clinical significance of c-MYC/EZH-2 expression and Merlin loss." 32nd EORTC-NCI-AACR symposium Molecular Targets and Cancer Therapeutics , Brussels, Belgium, p.42.

@conferencepaper{conferencepaper, author={AHMET MELİH ARSLAN}, title={Clinical significance of c-MYC/EZH-2 expression and Merlin loss}, congress name={32nd EORTC-NCI-AACR symposium Molecular Targets and Cancer Therapeutics}, city={Brussels}, country={Belgium}, year={2020}, pages={42} }